Detalhe da pesquisa
1.
TSC2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas.
Histopathology
; 83(4): 569-581, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679051
2.
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 23(2): 279-291, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35033226
3.
Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging.
Blood Adv
; 7(16): 4633-4646, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196647
4.
Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors.
Sci Adv
; 9(39): eadd9668, 2023 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37756410
5.
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit.
JCO Precis Oncol
; 6: e2100413, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797509
6.
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer.
Clin Cancer Res
; 27(9): 2470-2480, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33568343
7.
Correction: A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer.
Clin Cancer Res
; 27(17): 4940, 2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470811